Related Experiment Videos
Problem solving and diabetes self-management: investigation in a large, multiracial sample.
Russell E Glasgow1, Lawrence Fisher, Marilyn Skaff
1Clinical Research Unit, Kaiser Permanente Colorado, P.O. Box 378066, Denver, CO 80237-8066, USA. russg@ris.net
Diabetes Care
|December 29, 2006
Summary
Effective diabetes self-management relies on problem-solving skills. This study found that problem-solving abilities, measured by the Diabetes Problem-Solving Interview (DPSI), are crucial for managing type 2 diabetes across diverse populations.
Area of Science:
- Endocrinology
- Behavioral Medicine
- Psychology
Background:
- Problem-solving is vital for chronic illness self-management, particularly for diabetes.
- Objective evaluations of problem-solving skills in large, diverse patient samples are limited.
Purpose of the Study:
- To objectively evaluate problem-solving skills in adults with type 2 diabetes.
- To examine the relationship between problem-solving skills and various patient characteristics, self-management behaviors, and health outcomes.
Main Methods:
- A multiracial sample of 506 adults with type 2 diabetes completed the Diabetes Problem-Solving Interview (DPSI).
- Assessments included patient characteristics, self-management behaviors, biological measures (A1C, lipids), and psychosocial measures (Diabetes Distress Scale).
Main Results:
- DPSI scores showed significant patient variability in problem-solving skills.
- Problem-solving ability was associated with comorbid conditions, self-management behaviors (diet, exercise), biological variables, and psychosocial factors.
- No significant associations were found with race/ethnicity.
Conclusions:
- Diabetes problem-solving, assessed via DPSI, is a key patient skill linked to critical diabetes management variables.
- This skill appears applicable across diverse racial and ethnic groups.
- Further research should explore the generalizability of these findings and develop interventions to improve problem-solving skills.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...